EU Agencies Enhance Collaboration to Speed Up Health Innovation
The European Medicines Agency (EMA) and the European Innovation Council and SMEs Executive Agency (EISMEA) have formalized a new work program for 2026–2027. This collaboration aims to streamline the regulatory process for early-stage biopharmaceutical and medical technology developers. The initiative seeks to accelerate the availability of innovative medicines and health solutions for patients across the EU.
Want more?
Open NewsSnap.ai for the full app experience, including audio, personalization, and more news tools.